Medtronic, Inc. Receives FDA Panel’s Recommendation for Approval of the Bryan(R) Cervical Disc

MEMPHIS, Tenn.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced the Bryan® Cervical Disc has received a recommendation for approval from the U.S. Food and Drug Administration’s (FDA) Orthopedic and Rehabilitation Devices advisory panel. The panel recommended a variety of conditions that will be considered by the FDA during its ongoing review process.

MORE ON THIS TOPIC